Torrent Pharmaceuticals Limited vs Ajanta Pharma Limited
An objective side-by-side of TORNTPHARM and AJANTPHARM, both in Pharmaceuticals - Indian - Formulations: valuation, profitability, growth, balance sheet, ownership and share-price performance. Where one number is clearly better on its own terms (lower P/E, higher ROE), it is shaded. That is a description, not a recommendation.
Prices as of 2026-11-05 close
Latest results: TORNTPHARM Sep 2026 · AJANTPHARM Sep 2026
At a glance
- Torrent Pharmaceuticals Limited is the larger company by market value, about 4.4 times the size of Ajanta Pharma Limited.
- On trailing earnings, Ajanta Pharma Limited trades at the lower P/E (32.5 against 85.4).
- Ajanta Pharma Limited earns the higher return on equity (27.9% against 25.0%).
- Over three years Torrent Pharmaceuticals Limited has grown profits faster (22% a year against 21%).
- Over the past year the share prices returned +30.8% (TORNTPHARM) and +33.0% (AJANTPHARM).
| Metric | Torrent Pharmaceuticals TORNTPHARM |
Ajanta Pharma AJANTPHARM |
|---|---|---|
| Size and price | ||
| Market cap | ₹179,153 Cr | ₹41,013 Cr |
| Share price | ₹4,710.00 | ₹3,282.10 |
| Valuation | ||
| P/E | 85.35 | 32.47 |
| P/B | 21.36 | 9.06 |
| EV/EBITDA | 33.63 | 24.47 |
| PEG | 3.88 | 1.55 |
| Dividend yield | 0.8% | 0.9% |
| Profitability | ||
| ROE | 25.0% | 27.9% |
| ROCE | 15.0% | 32.0% |
| Operating margin | 33.2% | 27.1% |
| Sales (TTM) | ₹17,400 Cr | ₹6,217 Cr |
| Net profit (TTM) | ₹2,099 Cr | ₹1,263 Cr |
| Growth | ||
| Latest quarter sales YoY | +50.8% | +32.5% |
| Latest quarter profit YoY | -9.6% | +49.2% |
| Sales CAGR 3Y | +13.0% | +13.0% |
| Profit CAGR 3Y | +22.0% | +21.0% |
| Sales CAGR 5Y | +12.0% | +14.0% |
| Profit CAGR 5Y | +12.0% | +10.0% |
| Financial strength | ||
| Debt/Equity | 1.79 | 0.06 |
| Interest cover | 8.94 | 77.57 |
| Ownership | ||
| Promoter holding | 60.8% | 63.5% |
| Promoter change (4 qtrs) | -7.53 pp | -2.78 pp |
| Price performance | ||
| Return 1M | -1.30% | -8.15% |
| Return 3M | -5.80% | -4.52% |
| Return 1Y | +30.75% | +32.95% |
| Return YTD | +22.34% | +18.53% |
| Technical condition | ||
| Technical score | 72 | 28 |
| RS rating (1-99) | 74.00 | 75.00 |
| % vs 200-DMA | +4.10% | +3.35% |
| RSI (14) | 52.87 | 40.08 |
| % from 52-week high | -10.29% | -13.54% |
